Piperidinyl derivatives as modulators of chemokine receptor activity
摘要
<p>The present application describes substituted piperidinyl modulators of MIP-1± or CCR-1 or stereoisomers or pharmaceutically acceptable salts thereof. In addition, methods of treating and preventing inflammatory diseases such as asthma and allergic diseases, as well as autoimmune pathologies such as rheumatoid arthritis and transplant rejection using said modulators are disclosed.</p>
